소장자료
| LDR | 05776nam a22004097a 4500 | ||
| 001 | 0009304397▲ | ||
| 005 | 20231025115330▲ | ||
| 008 | 070108s2006 sz a b i100 0 eng d▲ | ||
| 020 | ▼a 9241547103▲ | ||
| 020 | ▼a 9789241547109▲ | ||
| 035 | ▼a (OCoLC)77550638▲ | ||
| 040 | ▼aHNC▼cHNC▼dNTE▼dCOD▼dIXA▼dUIU▼dUk▼d221016▲ | ||
| 082 | 0 | 4 | ▼a 614.55 ▼2 21▲ |
| 090 | ▼a 614.55 ▼b P944c▲ | ||
| 245 | 0 | 0 | ▼aPreventive chemotherapy in human helminthiasis :▼bcoordinated use of anthelminthic drugs in control interventions : a manual for health professionals and programme managers.▲ |
| 260 | ▼aGeneva, Swizterland:▼bWorld Health Organization,▼c2006.▲ | ||
| 300 | ▼aix, 62 p.:▼bcol. ill.;▼c26 cm+▼eforms, dosage calculators.▲ | ||
| 500 | ▼a "A first draft of this manual was prepared by the World Health Organization (WHO) in consultation with Professor D.W.T. Crompton, Institute of Biomedical and Life Sciences, University of Glasgow, Scotland. After circulation to a number of experts, the draft was revised in the light of their comments and input. It was further reviewed at the Informal Consultation on Preventive Chemotherapy in Human Helminthiasis, which took place at WHO headquarters in Geneva, Switzerland, on 16-17 March 2006. Subsequently, WHO staff, in close collaboration with Professor D.W.T. Crompton, who chaired the Informal Consultation, undertook further revision of the manual on the basis of comments and suggestions made by participants. The resulting draft was circulated to all concerned before being finalized for publication. "--P. vi.▲ | ||
| 504 | ▼a Includes bibliographical references.▲ | ||
| 505 | 0 | ▼a 1. Meeting the challenge -- -- 2. Situation analysis -- -- 3. Preventive chemotherapy and its role in the control of helminthiasis -- 3.1 Aim and rationale -- 3.2 Ancillary benefits and advantages of preventive chemotherapy -- -- 4. WHO-recommended drugs: alone and in combination -- -- 5. Preventive chemotherapy: best practice -- 5.1 Eligibility and ineligibility for treatment -- 5.2 Safety and adverse reactions -- 5.2.1 Safety of drug combinations for treatment of helminth infections -- 5.2.2 Safety in pregnancy -- 5.3 Drug quality -- 5.4 Programme implementation -- 5.4.1 Drug delivery and incorporation into established and novel programmes -- 5.4.2 Implementation charts--how to intervene -- 5.5 Different age groups and special risk groups in preventive chemotherapy -- 5.5.1 Preschool children (aged 1-5 years) -- 5.5.2 School-age children (aged 6-15 years) and adults (aged >15 years) -- 5.5.3 Adolescent girls, women of reproductive age and pregnant women -- 5.6 Problems caused by concurrent infections -- -- 6. Measuring and monitoring during preventive chemotherapy -- 6.1 Coverage -- 6.2 Evaluation of impact on morbidity and transmission -- 6.3 Threat of drug resistance and monitoring of drug efficacy -- -- Annexes -- I. Occurrence of lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiasis and loiasis in countries and territories where preventive chemotherapy interventions may need to be implemented -- II. Rapid assessment and decision charts for schistosomiasis and soil-transmitted helminthiasis -- III. Standardized form for recording serious adverse experiences -- IV. Drug supply, recommended dosages and dose poles -- V. Coverage forms -- VI. Disease-specific information▲ | |
| 520 | ▼a This manual is intended to guide the coordinated implementation of regular, systematic, large-scale interventions that provide anthelminthic drug treatment as a core component of the joint and synergic control of helminthic diseases such as lymphatic filariasis, onchocerciasis, schistosomiasis and soil-transmitted helminthiasis. The manual focuses mainly on antihelminthic treatment, but other drugs used to eliminate other agents can be potentially associated to those mentioned in the manual; as a reference trachoma control through the SAFE strategy, combining drug treatment with hygiene and environmental management, can be associated to helminth control interventions to boost the overall health of affected communities. The greatest challenge is to extend regular anthelminthic drug coverage as a public health intervention to reach all individuals at risk of the morbidity caused by helminthic infections. Preventive chemotherapy should therefore begin early in life, and every opportunity should be taken to reach at-risk populations. This manual advocates much greater coordination among disease control interventions . Because such large numbers of people are affected, and are often difficult to reach, it also stresses the need to make the best use of all existing drug distribution channels to deliver anthelminthic drugs, and aims at encouraging program managers to find other innovative means of reaching those in need in a sustainable manner.--Publisher's description.▲ | ||
| 530 | ▼a Also available via the World Wide Web as an Arobat .pdf file (1.57 MB, 74 p.); drug dosage caluculators (135 KB, 6 p.).▲ | ||
| 650 | 0 | ▼a Anthelmintics.▲ | |
| 650 | 0 | ▼a Drugs▼x Dosage.▲ | |
| 650 | 0 | ▼a Helminthiasis▼x Chemotherapy.▲ | |
| 650 | 0 | ▼a Helminthiasis▼x Prevention.▲ | |
| 650 | 0 | ▼a Anthelmintics▼x administration & dosage.▲ | |
| 650 | 0 | ▼a Helminthiasis▼x drug therapy.▲ | |
| 650 | 0 | ▼a Helminthiasis▼x prevention & control.▲ | |
| 650 | 2 | ▼a Anthelmintics▼x administration & dosage.▲ | |
| 650 | 2 | ▼a Helminthiasis▼x drug therapy.▲ | |
| 650 | 2 | ▼a Helminthiasis▼x prevention & control.▲ | |
| 700 | 1 | ▼a Crompton, D. W. T.▼q (David William Thomasson),▼d1937-▲ | |
| 710 | 2 | ▼a World Health Organization.▲ | |
| 990 | ▼a 정영주▼b정영주▲ |
Preventive chemotherapy in human helminthiasis : coordinated use of anthelminthic drugs in control interventions : a manual for health professionals and programme managers
자료유형
국외단행본
서명/책임사항
Preventive chemotherapy in human helminthiasis : coordinated use of anthelminthic drugs in control interventions : a manual for health professionals and programme managers.
개인저자
Crompton, D. W. T. (David William Thomasson) , 1937-
발행사항
Geneva, Swizterland : World Health Organization , 2006.
형태사항
ix, 62 p. : col. ill. ; 26 cm + forms, dosage calculators.
일반주기
"A first draft of this manual was prepared by the World Health Organization (WHO) in consultation with Professor D.W.T. Crompton, Institute of Biomedical and Life Sciences, University of Glasgow, Scotland. After circulation to a number of experts, the draft was revised in the light of their comments and input. It was further reviewed at the Informal Consultation on Preventive Chemotherapy in Human Helminthiasis, which took place at WHO headquarters in Geneva, Switzerland, on 16-17 March 2006. Subsequently, WHO staff, in close collaboration with Professor D.W.T. Crompton, who chaired the Informal Consultation, undertook further revision of the manual on the basis of comments and suggestions made by participants. The resulting draft was circulated to all concerned before being finalized for publication. "--P. vi.
서지주기
Includes bibliographical references.
내용주기
1. Meeting the challenge -- -- 2. Situation analysis -- -- 3. Preventive chemotherapy and its role in the control of helminthiasis -- 3.1 Aim and rationale -- 3.2 Ancillary benefits and advantages of preventive chemotherapy -- -- 4. WHO-recommended drugs: alone and in combination -- -- 5. Preventive chemotherapy: best practice -- 5.1 Eligibility and ineligibility for treatment -- 5.2 Safety and adverse reactions -- 5.2.1 Safety of drug combinations for treatment of helminth infections -- 5.2.2 Safety in pregnancy -- 5.3 Drug quality -- 5.4 Programme implementation -- 5.4.1 Drug delivery and incorporation into established and novel programmes -- 5.4.2 Implementation charts--how to intervene -- 5.5 Different age groups and special risk groups in preventive chemotherapy -- 5.5.1 Preschool children (aged 1-5 years) -- 5.5.2 School-age children (aged 6-15 years) and adults (aged >15 years) -- 5.5.3 Adolescent girls, women of reproductive age and pregnant women -- 5.6 Problems caused by concurrent infections -- -- 6. Measuring and monitoring during preventive chemotherapy -- 6.1 Coverage -- 6.2 Evaluation of impact on morbidity and transmission -- 6.3 Threat of drug resistance and monitoring of drug efficacy -- -- Annexes -- I. Occurrence of lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiasis and loiasis in countries and territories where preventive chemotherapy interventions may need to be implemented -- II. Rapid assessment and decision charts for schistosomiasis and soil-transmitted helminthiasis -- III. Standardized form for recording serious adverse experiences -- IV. Drug supply, recommended dosages and dose poles -- V. Coverage forms -- VI. Disease-specific information
요약주기
This manual is intended to guide the coordinated implementation of regular, systematic, large-scale interventions that provide anthelminthic drug treatment as a core component of the joint and synergic control of helminthic diseases such as lymphatic filariasis, onchocerciasis, schistosomiasis and soil-transmitted helminthiasis. The manual focuses mainly on antihelminthic treatment, but other drugs used to eliminate other agents can be potentially associated to those mentioned in the manual; as a reference trachoma control through the SAFE strategy, combining drug treatment with hygiene and environmental management, can be associated to helminth control interventions to boost the overall health of affected communities. The greatest challenge is to extend regular anthelminthic drug coverage as a public health intervention to reach all individuals at risk of the morbidity caused by helminthic infections. Preventive chemotherapy should therefore begin early in life, and every opportunity should be taken to reach at-risk populations. This manual advocates much greater coordination among disease control interventions . Because such large numbers of people are affected, and are often difficult to reach, it also stresses the need to make the best use of all existing drug distribution channels to deliver anthelminthic drugs, and aims at encouraging program managers to find other innovative means of reaching those in need in a sustainable manner.--Publisher's description.
이용가능한 다른형태자료 주기
Also available via the World Wide Web as an Arobat .pdf file (1.57 MB, 74 p.); drug dosage caluculators (135 KB, 6 p.).
주제
ISBN
9241547103 9789241547109
청구기호
614.55 P944c
소장정보
예도서예약
서서가에없는책 신고
방방문대출신청
보보존서고신청
캠캠퍼스대출
우우선정리신청
배자료배달신청
문문자발송
출청구기호출력
학소장학술지 원문서비스
| 등록번호 | 청구기호 | 소장처 | 도서상태 | 반납예정일 | 서비스 |
|---|
북토크
자유롭게 책을 읽고
느낀점을 적어주세요
글쓰기
느낀점을 적어주세요
청구기호 브라우징
관련 인기대출 도서